Indian company acquires rights to copy generic cancer drug
Indian pharmaceutical company, Natco Pharma, has been authorized to manufacture an expensive anti-cancer drug originally developed by Bayer Corporation. This move, although undermining the Bayer’s patent, is expected to make this drug, employed in liver and kidney cancer, cheaper and more widely available. Under the ruling by the controller of patents More...
Shantha Biotech targeting global orders
Shantha Biotech is expecting orders from international organisations for its flagship pentavalent vaccine which is under clinical trials, currently. The company based in Hyderabad, India, was bought by French More...
Marketing application withdrawn: Cell Therapeutics Inc.
On Monday, Cell Therapeutics Inc said that it has willingly withdrawn the application for marketing its cancer drug – Pixuvri. This sent down its shares by 17 percent before the bell. The company said that More...
GW Pharmaceuticals seeks FDA permission for Sativex
Sativex, is the world’s first marijuana based prescription drug, developed by GW Pharmaceuticals, a British pharmaceutical company. This drug, developed as a mouth spray, has two best known psychoactive ingredients More...
FDA Grants clearance to a disinfecting port protector
Carlsbad, California (USA) – Ivera Medical Corporation today announced that it has received a new FDA 510(k) clearance for its Curos disinfecting port protector. The Curos passive disinfection cap first More...
Novo Nordisk partners with American Cooking Stars
Princeton (USA) – Novo Nordisk, the world leader in diabetes care, is teaming up with American cooking stars Paula Deen and her sons, Bobby and Jamie Deen, to launch Diabetes in a New Light™,a national initiative More...
Wockhardt gets US FDA’s consent for Fluticasone nasal spray
US Food and Drug Administration recently gave its final approval to drug firm Wockhardt for marketing of generic Fluticasone nasal spray, in the American market. Fluticasone nasal spray is generally used for treating More...
Psoriasis drug under Clinical Trials, fairs well: Biocon
According to a recent e-mailed statement from Biocon Ltd – a Bangalore, India based global biopharmaceutical company; Itolizumab- its experimental drug for Psoriasis, has met the main goal of a late- stage clinical More...
Ranbaxy gets Green signal for Lipitor from US FDA
US Food and Drug Administration grants Ranbaxy Laboratories a final approval for Atrovastatin Calcium -Abbreviated New Drug Application (ANDA) in multiple strengths of 10 mg, 20 mg, 40 mg and 80 mg. Pfizer first More...
IBM’s new software launch: turns over a new leaf in the healthcare segment
Healthcare providers and payers can now analyze world’s data very efficiently, to provide improved patient care at reduced costs, with latest software introduced by IBM on October 25, 2011. Interestingly, this More...